Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

administration

administration is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 120
News articles 0
Drug details — administration
Class
—
Route
—
Patents
20
Programs
120
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

administration is an FDA-listed pharmaceutical active ingredient.

Key facts

INN administration

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 1821-FSH-301 Phase 3 · Fulcrum Therapeutics · Facioscapulohumeral Muscular Dystrophy (FSHD)
  2. AG120-C-009 Phase 3 · George Institute for · Previously Untreated Acute Myeloid Leukemia with an IDH1 Mut
  3. AG348-C-020 Phase 3 · Anaxis Pharma · Anemia in subjects with sickle cell disease (SCD)
  4. AG881-C-004 Phase 3 · George Institute for · Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mu
  5. AV-299-23-301 Phase 3 · Anaxis Pharma · Head and Neck Squamous Cell Carcinoma (HNSCC)
  6. EORTC-2427-BTG Phase 3 · Ningbo Cancer Hospital · ​​IDH-mutant grade 2 or 3 astrocytoma​
  7. ION-682884-CS2 Phase 3 · IONIS PHARMACEUTICALS · Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
  8. Intravenous methylene blue administration Phase 3 · Hospital Authority · Severe Sepsis

Related patents

Browse patents

  1. WO 2026060304

    ADMINISTRATION SOUS-CUTANÉE D'UN AGENT ANTI-DLL3 POUR LE TRAITEMENT DU CANCER

    Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026027759

    AGENTS ET MÉTHODES POUR UNE ADMINISTRATION CIBLÉE À DES CELLULES

    Expires Wed Jan 31 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025262460

    COMPOSITIONS LIPIDIQUES POUR L'ADMINISTRATION D'ACIDES NUCLÉIQUES

    Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2025210141

    SYSTÈME D'ADMINISTRATION UTILE POUR L'ADMINISTRATION TOPIQUE D'ARN

    Expires Wed Oct 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12419890

    Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12403154

    Administration of sting agonist and checkpoint inhibitors

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12390453

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12383572

    Administration of an anti-activin-a compound to a subject

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12371506

    Subcutaneous administration of anti-CD38 antibodies

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12357555

    Self-emulsifying composition, intended for administration onto the skin, containing biosurfactant, cosurfactant and oil phase

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12344665

    Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2025133253

    EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE

    Expires Wed Jun 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12329772

    Methods and compositions for administration of iron

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12331099

    VEGF antagonist formulations suitable for intravitreal administration

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. WO 2025077836

    LIPIDES IONISABLES ET NANOPARTICULES LIPIDIQUES POUR ADMINISTRATION D'ARN

    Expires Wed Apr 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12226404

    Methods for making compositions for pulmonary administration

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12214083

    Pharmaceutical composition and administrations thereof

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 2025002606

    Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA

    Expires Wed Dec 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12178981

    Drug administration method

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12102642

    Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is administration?

administration is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.